Page 24 - Read Online
P. 24

cardiotoxicity linked to the use of Notch inhibitors. [63]  in the late pre-mRNA  has also been detected. [79,80]  SV40
                                                              is phylogenetically,  closely  related  to HPyV.  There  is
           The  mutations  causing the activation  of Notch signaling   evidence of similarity with respect to size (about 5.2 Kb),
           have  been  identified  for  T-ALLs;  however,  little  is   genome  organization,  and  DNA  sequence.  The  tags  of
                                         [38]
           known about  the molecular  mechanism  involved  in   SV40,  BKPyV, and JCPyV  strongly  cross-react  with the
           dysregulating Notch in other malignancies. Few activating   same antisera [81,82]   while  a less, strong  cross-reactivity  is
           mutations of the Notch pathway have been found in solid   observed in most structural  antigenic  determinants  of
           tumor  patients,  with most being  observed in non-small   the  viral  proteins,  named VP1,  2  and  3. A genus-specific
           cells lung   and head and neck cancers.   In breast and   capsid antigen,  located  on viral  peptide  VP1, has  been
                   [64]
                                             [65]
           lung cancers, inactivation  of  Numb, a  protein  involved   identified.   The  DNA  sequences of  SV40 share 70%
                                                                      [83]
           in  Notch1  downregulation,  has  also  been  identified. [64,66]    homology  with  BKPyV,   and  69% with JCPyV.  The
                                                                                                       [85]
                                                                                  [84]
           Rearrangements  of the Notch  gene families  have been   greatest homology is found in the early region coding for
           found in breast cancer. [67]                       the Tags and tags, whereas a lower homology is detected
                                                              in the regulatory region.
           THE ROLE OF SMALL DNA TUMOR VIRUSES
           IN THE PATHOGENESIS OF CANCER                      Transformation  of rodent and human cells by  SV40
                                                              is  induced  by the  2 oncoproteins,  Tag and tag,  which
           SV40                                               display  multiple functions.  The main  activity  of  Tag
                                                                                 [69]
           SV40  is a monkey virus, which was accidentally    for cell  transformation  and  tumorigenesis  is to target
                [68]
           administered to humans, in the years 1955-1963, through   key cellular proteins, [86-88]   such  as the  tumor suppressor
           contaminated  poliovirus vaccines. [69,70]  However, a more   p53 [89-91]   and  retinoblastoma  protein  (pRB)  family
           recent  study indicates  that some oral poliovirus vaccines   proteins,  inactivating  their  functions. [92-94]   SV40 Tag  may
           were contaminated with infectious SV40 in sub-sequent   also  lead to  transformation  by  inducing  mutations  to  the
                                                                           [95]
           years.  Early experiments  both  in vitro and  in vivo   cellular genome   or numerical  and structural  alterations
                [71]
           classified SV40 as a transforming and oncogenic viral agent.   of chromosomes, [96,97]   such  as gaps, breaks, dicentric
           These activities are due to SV40 large tumor antigen (Tag)   and ring chromosomes, chromatid  exchanges, deletions,
                                                                                        [98]
           and small tumor antigen (tag), which act as activated viral   duplications,  and translocations.   The  principal  role of
           oncogenes. [69,70]   These studies addressed a new wave of   the tag in transformation is to bind the catalytic (36 kDa)
           investigations into the potential of SV40 to induce cancer in   and regulatory (63 kDa) sub-units of protein phosphatase
           humans. To date, hundreds of molecular and epidemiologic   2A (PP2A), [69,86]   inactivating  their  function.  Moreover,
           studies  aimed  at  investigating  whether  SV40 infects   tag interacts with  the centrosome  and  blocks mitosis in
                                                                        [99]
           humans, its potential mode of transmission and its putative   human cells,   suggesting  that it  may  disrupt  cell  cycle
           role in human tumors have been carried out. [72-74]  progression. Recently, it  has been  shown  that in  human
                                                              mammary epithelial cells tag activates PI3K [100]   an enzyme
           SV40  was assigned to the family of Papovaviridae, an   involved  in  pathways crucial  for cell  proliferation,  and
           acronym  proposed  by Melnick  obtained  by fusing the   transformation  through phosphorylation  of the hydroxyl
                                     [75]
           names of the 3 representative viruses papilloma, polyoma,   moiety  present on the phosphatidylinositol  inositol
           and vacuolating  agent. However, this nomenclature  at   ring. Aberrant regulation  of EGFR upstream  from PI3K
           present is considered obsolete. More recently, SV40 has   through mutations in EFGR can lead to cancer promotion
           been enclosed  among polyomaviruses, together  with   in glioblastoma. [101,102]   In addition, SV40 tag can enhance
           the human polyomaviruses (HPyV),  BK  Polyomavirus   transcription  from E2F-activated  promoters of early
           (BKPyV),  and JC polyomavirus (JCPyV).  The virion is   growth response genes. [103,104]   The process  of rodent  cell
           about 45 nm, an icosahedral particle, with a density of 1.34-  transformation induced by SV40 typically depends on the
           1.35 g/cm . The viral genome is a circular, double-stranded   integration  of  the  viral  DNA  into  the  host genome
                   3
           DNA molecule. SV40 encodes for six main viral proteins:   where it produces a high level of expression of the major
           Two early  non-structural polypeptides,  Tag  and  tag,  an   viral  oncogenic  proteins,  Tag, and tag.  However, human
           agnoprotein,  probably  involved  in  the  assembly  of  viral   cells  experimentally transformed by SV40  harbor  viral
           particles and processing of  late messenger RNA (mRNA)   genomes in an  episomal  state in  addition  to  integrated
           and 3 capsid proteins, VP1,  VP2 and  VP3. [76-78]  The early   viral  DNA.  SV40  immortalized [105]   and transformed
           and late genes are transcribed on different DNA strands in   human  cells [106-108]   can  induce  tumors when implanted
           a way that the transcription proceeds divergently from the   subcutaneously in autologous  hosts. [107]   An  SV40 Tag
           regulatory region. This region contains the origin of DNA   needs  cooperation  of  the  catalytic sub-unit  of telomerase
           replication  and binding  sites  for the  transcription  factors   and  the  activated  c-HRas oncogene,  for the  complete
           that  control  viral  gene  expression  and  terminates  within   transformation of human cells, as shown in cotransfection
           DNA  sequences  containing  the polyadenylation  signals.   experiment. [109]   SV40  is highly oncogenic  in rodents
           Recently,  a predicted  late polarity pre-microRNA  to the   and when  inoculated subcutaneously,  intra-cerebrally,
           untranslated region 3’  of the polyadenylation cleavage site   or intra-venously in  newborn  hamsters  induces  soft

            14
                                                                                                      Journal of Cancer Metastasis and Treatment  ¦  Volume 2 ¦ Issue 1 ¦ January 15, 2016 ¦
   19   20   21   22   23   24   25   26   27   28   29